Navigation Links
Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
Date:3/16/2011

may not start when planned, be completed in a timely manner and/or confirm previous results; the clinical trial mentioned in this press release may not be restarted; our clinical studies may not be predictive or achieve intended results; our product candidates, including pramlintide/metreleptin for the treatment of obesity and metreleptin to treat diabetes and/or hypertriglyceridemia in patients with lipodystrophy, may not receive regulatory approval; and inherent scientific, regulatory and other risks associated in the drug development and commercialization process. These and additional risks and uncertainties are described more fully in Amylin's most recently filed SEC documents, including its Annual Report on Form 10-K. Amylin undertakes no duty to update these forward-looking statements.

Forward-Looking Statements Related to Takeda

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to, (
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
2. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
3. Amylin Pharmaceuticals Reports 2010 Financial Results
4. Amylin Pharmaceuticals to Webcast Year-End Financial Results
5. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
7. Amylin Pharmaceuticals Reports Third Quarter Financial Results
8. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
9. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
10. Amylin Pharmaceuticals to Webcast Third Quarter Results
11. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014  Mariel Therapeutics, Inc., a clinical stage ... application in Osteoarthritis (OA) and Chronic Kidney Disease (CKD), ... newly formed scientific advisory board. The newly appointed SAB ... to the company as it continues to develop therapies ... to have such leading experts in the area of ...
(Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
(Date:9/15/2014)... Research and Markets has announced the addition ... Analytics, Delivery Modes & by Whole Slide Image Storage ... to their offering. This report broadly ... and applications. Scanners accounted for the largest share of ... analytics market is expected to grow at the highest ...
Breaking Medicine Technology:Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 2Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 3Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 4Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
... YORK, April 28, 2011 Reportlinker.com announces ... available in its catalogue: ... System and Drug Regulatory Overview: Cost-containment and ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html Introduction ...
... NEW YORK, April 28, 2011 Reportlinker.com announces that ... catalogue: Pharmaceutical Key Trends 2011 ... http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html Introduction ... developed pharmaceutical markets, driven by increasing generic competition. However, ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 3
(Date:9/16/2014)... Florida (PRWEB) September 16, 2014 ... of monthly specials this month, kicking off September ... day spa in Clearwater, FL chose to highlight ... for immediate activation upon contact with the skin. ... part of their best-selling lumafirm® anti-aging line. The ...
(Date:9/16/2014)... The Fertility Centers of New England is proud ... collaboration will give patients access to high-quality frozen donor ... Fertility Centers of New England. , Fairfax Egg Bank ... selection of frozen donor eggs. Access to frozen donor ... The Donor is already screened and her eggs ...
(Date:9/15/2014)... With the variety of drugs passing ... know the details on each one. However, it is ... falling into their teen’s hands. , Synthetic marijuana ... high school students. With varied, misleading and potentially unreliable ... can be difficult for parents to separate the truth ...
(Date:9/15/2014)... iFitDress.com, one of the most distinguished dress companies, ... evening dresses to its online store. In addition, the ... products. They are now provided at very low prices, up ... has confidence in the newly unveiled sapphire evening outfits. “I ... from all over the world. Up to now, over 200 ...
(Date:9/15/2014)... 2014 Aging skin inevitably wrinkles, thins and ... is loss of collagen production. By age 60, skin ... to this slow down. Collagen holds up skin structure. , ... be boosted. There are several ways to do this, but ... cells (non-embryonic). , "The cost is higher than other types ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2Health News:A Superior Way to Make Skin Younger and Assure Continual Collagen Production, from Sublime Beauty® 2
... A Pole who spent 19 years in a coma has woken up ... are no longer in power, a television station announced Friday. ... by a train in 1988, the private channel Polsat said. In an ... ,"She's the one who always took care of me. She ...
... man has contracted the deadly bird flu virus, becoming the country's ... Saturday. ,The 19-year-old man tested positive for the H5N1 strain ... Institute of Tropical Medicine in Hanoi, a doctor there told AFP. ... the victim had been admitted on May 19 and was now ...
... one source of counterfeit medicines, seized in the European Union ... ,About 31 percent of all fake medicines seized ... percent) and China (8). The three countries are responsible for ... report. ,The seized fake medicines included Viagra, Cialis ...
... found evidence that tropical cyclones and hurricanes play an ... transport heat and maintain the climate of North America ... University professor of earth and atmospheric sciences who led ... by MIT professor Kerry Emanuel that suggests there is ...
... Inc. announced it has successfully expanded the potential ... ELISA diagnostic research test, FAS-Detect(TM) ELISA for ... ,The current diagnostic technique for this disease is ... use presently, FASgen anticipates the opportunity for use ...
... a third child, but the actor is recoiling from making ... not come out in the open to declare that his ... who interviewed the actor, is of the view that if ... forward, awareness about autism would get a major boost. ...
Cached Medicine News:Health News:India Main Source of Counterfeit Medicines Seized in Europe 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 3Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:FASgen Announces New Diagnostic Research Test for Steatohepatitis 2Health News:Travolta Maybe Reluctant to Publicaly Discuss About Sons Autism 2
... viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry ... 1000-5000 ... 0.8~1.5 Imprecision(%) ... 10 Dimensions: ...
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
Developed specifically for the 5000/5500 ultrasound consoles....
Super High Density, multi-frequency, phased array burr hole transducer. Excellent for taking biopsy samples and shunt placements....
Medicine Products: